NAV as on 18-02-2025
AUM as on 17-07-0036
Rtn ( Since Inception )
36.25%
Inception Date
Oct 04, 2023
Expense Ratio
2.13%
Fund Status
Open Ended Scheme
Min. Investment
100
Min. Topup
100
Min. SIP Amount
0
Risk Status
very high
Investment Objective : The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.